Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 31Plasma cell 8Myeloid 8Lymphoid 6CNS 5Sarcoma 4Genitourinary 4Gastrointestinal 4Thoracic 2Other solid neoplasm 2Gynecologic 2Dermatologic 2Classical hematology 2

Conditions

Lung Neoplasms 2Carcinoma, Small Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 463Cisplatin 379Paclitaxel 313Pemetrexed 300Docetaxel 242Erlotinib Hydrochloride 240Gemcitabine 232pembrolizumab 173Radiotherapy 172Bevacizumab 169Nivolumab 130Etoposide 106Gefitinib 95Vinorelbine 84durvalumab 71atezolizumab 68Cetuximab 65Topotecan 61Drug Therapy 57Ipilimumab 55Irinotecan 54osimertinib 53Radiosurgery 52Afatinib 51Surveys and Questionnaires 38130-nm albumin-bound paclitaxel 38Albumin-Bound Paclitaxel 37Taxes 35Cyclophosphamide 35Surgical Procedures, Operative 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Arsenic Trioxide × Thoracic × Clear all
NCT01470248 2021-02-17

Study of Arsenic Trioxide in Small Cell Lung Cancer

Emory University

Phase 2 Completed
20 enrolled 8 charts
Thoracic

Lung Neoplasms, Carcinoma, Small Cell

NCT00075426 2013-02-12

Arsenic Trioxide in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

The University of Texas Medical Branch, Galveston

Phase 2 Completed
30 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡